ORIONS Money Stocks

[novicetrader]

FLKS..SEC filing yesterday saying Notice of Delisting received on 8/13, but the odd thing is that day(8/13,monday) was the highest volume day since June 14 with an UPTICK and a high of 0.77! Usually goes down on that kind of news,right? No immediate impact of this Delisting notice and plenty of time(at least until Feb 11, 2019 or later) for this to be even occur,but the fact that the company stated their intent to resolve the deficiency,looks like a positive.Maybe someone/group accumulating believing/knowing that the price will be above a buck by that time?There had to be some reason for that kind of volume on monday,is my thinking.


https://www.sec.gov/Archives/edgar/data/1615219/000161521918000055/0001615219-18-000055-index.htm


Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On August 13, 2018, Flex Pharma, Inc. (the “Company) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the bid price of the Company’s common stock for the prior 30 consecutive business days had closed below the minimum $1.00 per share required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(a)(1).
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a period of 180 calendar days, or until February 11, 2019, to regain compliance. In order to regain compliance with the minimum closing bid price rule, the closing bid price of the Company’s common stock must be at least $1.00 or higher for a minimum of ten consecutive business days during the 180-day compliance period. In the event the Company does not regain compliance by February 11, 2019, the Company may be eligible to seek an extension of the compliance period if it meets the continued listing requirement for market value of publicly held shares and all other listing standards, with the exception of the bid price requirement, and provides written notice to Nasdaq of its intent to cure the deficiency. If the Company fails to regain compliance prior to the expiration of the compliance period including any extension, Nasdaq will provide written notice to the Company that its securities are subject to delisting.
The Notice has no immediate impact on the listing of the Company’s common stock, which will continue to trade on the Nasdaq Global Market under the symbol “FLKS”. The Company intends to actively monitor the closing bid price for its common stock and will consider available options to resolve the deficiency and regain compliance with Nasdaq Listing Rule 5450(a)(1).